Aurora Kinase VEGFR2 Inhibitor CYC116
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Enzyme Inhibitor ->
Protein Kinase Inhibitor -> Aurora Kinase VEGFR2 Inhibitor CYC116
Aurora Kinase VEGFR2 Inhibitor CYC116 Definition
An orally bioavailable small molecule multi-kinase inhibitor with antineoplastic activity. Aurora kinase/VEGFR 2 inhibitor CYC116 inhibits Aurora kinases A and B and vascular endothelial growth factor receptor 2 (VEGFR2), resulting in disruption of the cell cycle, rapid cell death, and the inhibition of angiogenesis. Aurora kinases are serine/threonine protein kinases that are only expressed in actively dividing cells and are critical in division or mitosis. VEGFR2 is a receptor tyrosine kinase that appears to account for most of the mitogenic and chemotactic effects of vascular endothelial growth factor (VEGF) on adult endothelial cells.
Aurora Kinase VEGFR2 Inhibitor CYC116 Synonyms
Aurora Kinase/VEGFR2 Inhibitor CYC116, CYC116
Terms in Aurora Kinase VEGFR2 Inhibitor CYC116 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.